Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Understanding when index funds are worth it depends on time horizon and fees. This quick guide outlines key scenarios and considerations.
14,180 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Prediction markets are moving into the mainstream. This piece examines whether Polymarket likely 2026? could bring an...
Nvidia sits at the heart of AI infrastructure, but its stock faces a potential shift this March. This guide breaks do...
February brought a sharp pullback for Robinhood, driven by crypto swings and a broader shift in its business model. T...
A stock trading earnings at a strikingly low multiple sits quietly in many portfolios. This article breaks down how t...
A new memoir and interview place Lloyd Blankfein at the center of a renewed debate over risk, accountability, and how...
FuelCell Energy stock just dropped after a mixed Q1 2026 report. In this analysis, we break down the what, why, and w...
The year 2025 saw disaster costs ease, yet losses exceeded $100 billion four times in five years. Insurers remain cau...
Investors are weighing XRP's chances as regulatory risk and crypto sentiment shift. This guide breaks down why here's...
AI disruption fears loom over software stocks. This article explains why Unity Software is likely to endure and even ...
CoreWeave sits at the center of the AI compute boom, offering scalable GPU capacity. This article breaks down the bul...
Nebius’s stock surges latest after the company lands a Meta partnership valued at up to $27 billion, building on a re...